Investor Presentaiton

Q3FY23 Performance Snapshot 3. & گاه Q3FY23 Key Highlights METROPOLIS The Pathology Specialist Total Revenue Rs. 286 Crores -3% YoY Revenue Excl. Covid PCR & Covid Allied tests Rs. 278 Crores 20% YOY Covid PCR & Allied Tests Revenue Rs. 8 Crores -88% YoY Volume (Excl. Covid PCR & Allied Tests) 6.2 Mn 14% YoY EBITDA Margin (Before CSR & ESOP) 27.1% Q3FY22 includes Hitech Diagnostics w.e.f 22nd Oct 2021 Blood Tests | Diagnostics | Wellness Reported EBITDA Margin 25.5% 4

View entire presentation